We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+11.96%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$445M
AUM Growth
+$51.4M
Cap. Flow
+$26.8M
Cap. Flow %
6.02%
Top 10 Hldgs %
13.28%
Holding
846
New
291
Increased
146
Reduced
137
Closed
271

Top Buys

Rank Stock Value
1
KR icon
Kroger
KR
+$8.18M
2
ACN icon
Accenture
ACN
+$8.18M
3
GIS icon
General Mills
GIS
+$7.58M
4
LULU icon
lululemon athletica
LULU
+$5.81M
5
BBBY
Bed Bath & Beyond Inc
BBBY
+$4.82M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.7%
2 Technology 21.58%
3 Industrials 13.12%
4 Healthcare 11.03%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFL icon
226
Aflac
AFL
$64.4B
$595K 0.13%
13,830
+3,430
+33% +$154K
AMWD
227
DELISTED
American Woodmark
AMWD
$595K 0.13%
+6,500
New +$600K
AME icon
228
Ametek
AME
$55.7B
$588K 0.13%
+8,143
New +$603K
NOW icon
229
ServiceNow
NOW
$109B
$582K 0.13%
16,880
-18,230
-52% -$632K
FCN icon
230
FTI Consulting
FCN
$4.88B
$581K 0.13%
+9,600
New +$557K
VLO icon
231
Valero Energy
VLO
$90.5B
$578K 0.13%
+5,212
New +$585K
BIO icon
232
Bio-Rad Laboratories Class A
BIO
$8.47B
$572K 0.13%
1,982
+844
+74% +$233K
STLA icon
233
Stellantis
STLA
$16.5B
$572K 0.13%
30,300
+14,300
+89% +$313K
FIVN icon
234
FIVE9
FIVN
$1.96B
$571K 0.13%
16,514
+3,300
+25% +$107K
MFC icon
235
Manulife Financial
MFC
$73.2B
$566K 0.13%
+31,500
New +$594K
CTRA
236
DELISTED
Coterra Energy
CTRA
$562K 0.13%
23,600
-5,900
-20% -$138K
HXL icon
237
Hexcel
HXL
$8.28B
$562K 0.13%
8,462
-500
-6% -$34.1K
CLGX
238
DELISTED
Corelogic, Inc.
CLGX
$561K 0.13%
+10,801
New +$543K
TECD
239
DELISTED
Tech Data Corp
TECD
$560K 0.13%
+6,825
New +$562K
BOOT icon
240
Boot Barn
BOOT
$4.71B
$556K 0.13%
+26,794
New +$565K
WLL
241
DELISTED
Whiting Petroleum Corporation
WLL
$556K 0.13%
141
-108
-43% -$373K
DAR icon
242
Darling Ingredients
DAR
$9.62B
$555K 0.12%
27,900
-8,400
-23% -$152K
VSAT icon
243
Viasat
VSAT
$10.2B
$552K 0.12%
+8,400
New +$536K
WB icon
244
Weibo
WB
$1.92B
$550K 0.12%
6,200
-1,900
-23% -$207K
GMED icon
245
Globus Medical
GMED
$10.6B
$548K 0.12%
+10,854
New +$566K
XRX icon
246
Xerox
XRX
$357M
$547K 0.12%
22,802
-19,198
-46% -$543K
HOME
247
DELISTED
At Home Group Inc.
HOME
$547K 0.12%
13,978
+5,900
+73% +$212K
MS icon
248
Morgan Stanley
MS
$337B
$538K 0.12%
11,353
+6,453
+132% +$337K
VRNT
249
DELISTED
Verint Systems
VRNT
$537K 0.12%
23,774
-1,570
-6% -$34.1K
CFG icon
250
Citizens Financial Group
CFG
$30.1B
$535K 0.12%
13,757
-543
-4% -$22.6K

Similar funds

Bayesian Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bayesian Capital Management held 846 positions worth $445M, up 13% from $393M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Bayesian Capital Management deployed $26.8M of net new capital in Q2 2018, opening 291 new positions and adding to 146 existing holdings. Its largest new stake was Kroger: 325,365 shares worth $9.26M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $14.8M trimmed.

  • Bayesian Capital Management's largest Q2 2018 buy was Kroger: 325,365 shares worth $9.26M.
  • Bayesian Capital Management added most to Burlington in Q2 2018, an estimated $3.26M increase.
  • Bayesian Capital Management's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $14.8M.
  • Bayesian Capital Management fully exited Nike in Q2 2018, selling an estimated $3.43M.
  • Bayesian Capital Management's ten largest holdings make up 13% of its $445M portfolio in Q2 2018.
  • Bayesian Capital Management opened 291 new positions and closed 271 in Q2 2018.
  • Bayesian Capital Management's portfolio value rose 13% quarter-over-quarter to $445M.

Based on Bayesian Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.